ID: MRFR/Pharma/1343-HCR | 90 Pages | Published By Rahul Gotadki on March 2023
The gangrene market is projected to reach USD 2,926.6.6 Million by 2030 at 8.3% CAGR during the forecast period 2022-2030. Gangrene is defined as the death of body tissue(s) due to a lack of blood flow. A range of chronic conditions, as well as post-traumatic, post-surgical, and spontaneous reasons, can cause it. Dry, wet, and gas gangrene are the three types of gangrene. The risk of gas gangrene has increased as the occurrence of severe traumatic injury has increased, leading to the growth of the gangrene market. Gangrene is a disorder in which bodily tissues die as a result of a severe bacterial infection or a lack of blood supply. An injury, underlying sickness, or infection could be the cause of a lack of blood supply.
The following are some of the causes of gangrene:
Diabetes is one of the variables that increase the chance of developing gangrene. If you have diabetes, your body either doesn't create enough insulin (which helps your cells absorb blood sugar) or is resistant to insulin's effects. Blood arteries can be damaged by high blood sugar levels, reducing or halting blood flow to a section of the body. Blood clots and hardened and restricted arteries (atherosclerosis) can potentially impede blood flow to a part of the body. Any process that produces stress to your skin and underlying tissue, such as an injury or frostbite, raises your risk of developing gangrene, particularly if you have an underlying condition that limits blood flow to the wounded area. Smokers are more likely to develop gangrene. These all factors, therefore, increase the gangrene market value during the forecast period.
There have been a few instances of persons developing dry gangrene in their fingers and toes as a result of blood coagulation issues caused by COVID-19 (coagulopathy). This link needs to be confirmed by more research. The coronavirus strain that caused the disastrous Covid-19 epidemic in India is the most contagious to date which has increased the Gangrene Market Trends. Doctors are now trying to figure out if it's also more serious. Doctors in India have connected the so-called Delta variety to hearing loss, severe gastrointestinal disturbances, and blood clots leading to gangrene, symptoms not generally observed in Covid users.
Early evidence indicated that the now-dominant strain is associated with a higher incidence of hospitalization in England and Scotland. Delta has expanded to nearly 60 nations in the last six months, prompting travel restrictions. Higher rates of transmission relative to previous varieties, as well as a decrease in vaccination effectiveness, have made understanding the strain's impacts all the more important. Covid-19 sufferers in India are suffering from stomach pain, nausea, vomiting, loss of appetite, hearing loss, and joint pain, to name a few symptoms. During the last two months, some patients have developed microthrombi, or minute blood clots, that have caused affected tissue to die and develop gangrene. According to local media, doctors are also discovering clots growing in blood veins that supply the intestines, causing patients to have stomach pain as their only symptom.
Gangrene Market Dynamics
The rise in the occurrence of severe traumatic injury is likely to support the Market Growth in the foreseeable future. Furthermore, the rising prevalence of diabetes and the complications that come with it are expected to fuel the expansion of the Market. Also, the rising healthcare for infectious illness treatment in developed nations would open up new chances for the Market in the approaching years. Diabetes Incidence Is Increasing Across the Globe, thus, boosting the Gangrene Market growth.
The absence of effective therapy for the disease is expected to stymie the gangrene market value throughout the forecast period. The lack of healthcare facilities in many developed and developing countries may pose an additional hurdle to the market growth. Over the market Analysis period, however, the high cost of treatment and managing the illness is expected to act as a major limitation on the growth of the gangrene treatment medicines market.
The gangrene market offers extensive market information for technologies, prognosis, and remedies. Some of the data variables offered on the market include prevalence, incidence, mortality, and adherence rates. In the future years, technological advances and developments will provide profitable opportunities for Global gangrene Market participants. Even during the COVID era, gangrene is becoming increasingly prevalent among the world's population. As a result of technological advancements the installed base of various types of products for the Global gangrene Market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the Market are all increasing.
Gangrene Market Segment Overview
Based on the type, the market has been segmented as follows:
Based on the treatment, the market has been segmented as follows:
Based on the end-user, the market has been segmented as follows:
Gangrene Market Regional Analysis
North America is the largest gangrene market in the world. Because of the strong presence of significant key players, North America dominates the gangrene treatment industry. Furthermore, rising healthcare costs and increasing technological advancements in the healthcare sector would propel the gangrene treatment market in the area to new heights throughout the forecast period. Europe is Gangrene's second-largest market, and it is predicted to expand fast. The Asia-Pacific region is predicted to develop at the quickest rate in the Gangrene industry. Due to an increase in the number of cases of gangrene affecting the mouth, nose, and lips, Asia-Pacific is expected to see considerable growth in the gangrene treatment market. Furthermore, the region's gangrene treatment market is expected to develop in the next years due to an increase in the older population.
Gangrene Market Competitive Landscape
Company overview, financials, market potential, investment in research and development, new market initiatives, company strengths and weaknesses, product launch, clinical trial pipelines, application dominance, and technology lifeline curve are all included in the gangrene treatment market competitive landscape. The information presented above is only about the firms' concentration on the gangrene treatment market. Some of the major key players in the gangrene market are MediPurpose Private Limited (US), Baril Corporation (US), McKesson Corporation, Cardinal Health (Dublin), Advanced Medical Solutions Group plc (UK), Advanced Tissue (US), TRIAGE MEDITECH PVT. LTD. (India), Integra Life Sciences Corporation (US), Covalon Technologies Ltd. (Canada), and Others.
Gangrene Market Report Overview
The report depicts the current market landscape in detail, including historical and projected market size in terms of value and volume, technical advancements, and market controlling factors. The report also includes detailed information and plans for the industry's top major players. From technology-based analysis to market portfolio strategies, a market analysis of target competitors can be studied. The gangrene treatment market is examined, with data on market size broken down by country, kind, therapy type, treatment type, end-users, and area. The gangrene treatment market report examines opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market, as well as market share, new developments, and the impact of market players.
|Market Size||2,926.6.6 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Type, Treatment, End User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||MediPurpose Private Limited (US), Baril Corporation (US), McKesson Corporation, Cardinal Health (Dublin), Advanced Tissue (US), TRIAGE MEDITECH PVT. LTD. (India), Integra LifeSciences Corporation (US), Covalon Technologies Ltd. (Canada), Advanced Medical Solutions Group plc (UK) and others|
|Key Market Opportunities||New product launches and R&D Amongst major key Players|
|Key Market Drivers||The increasing rate of severe traumatic injury has increased the chance of gas gangrene|